Hyperkeratosis lenticularis perstans

Summary

Hyperkeratosis lenticularis perstans (MONDO:0007756) is a disease. A subtype of epidermal disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Prevalence: Unknown (Worldwide)
• Phenotypes (HPO): 7

Clinical features

Signs & symptoms

Clinical features (HPO)

7 HPO clinical features (Orphanet curated; top 7 by frequency):

HPO ID	Term	Frequency
HP:0007570	Hyperkeratosis lenticularis perstans	Very frequent (80-99%)
HP:0200034	Papule	Very frequent (80-99%)
HP:0000989	Pruritus	Frequent (30-79%)
HP:0200042	Skin ulcer	Frequent (30-79%)
HP:0002671	Basal cell carcinoma	Occasional (5-29%)
HP:0002860	Squamous cell carcinoma	Occasional (5-29%)
HP:0008065	Aplasia/Hypoplasia of the skin	Occasional (5-29%)

Identifiers

Disease identifiers

Field	Value
Canonical name	hyperkeratosis lenticularis perstans
Mondo ID	MONDO:0007756
MeSH	C538377
OMIM	144150
Orphanet	409
SNOMED CT	28488007
UMLS	C0263420
MedGen	120477
GARD	0002824
MedDRA	10071311
Is cancer (heuristic)	no

Also known as: Flegel disease · Flegel’s disease · HLP · hyperkeratosis lenticularis perstans · hyperkeratosis lenticularis perstans (disease) · hyperkeratosis lenticularis perstans of Flegel

Data availability: 1 HPO phenotype.

Disease family

This is a subtype of epidermal disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › integumentary system disorder › skin disorder › epidermal disease › hyperkeratosis lenticularis perstans

Related subtypes (24): porokeratosis, Darier disease, absence of fingerprints-congenital milia syndrome, keratolytic winter erythema, Hailey-Hailey disease, VPS13A-related neurodegenerative disease, acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome, keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome, seborrhea-like dermatitis with psoriasiform elements, psoriasis 14, pustular, palmoplantar pustulosis, hereditary poikiloderma, congenital erosive and vesicular dermatosis, neonatal inflammatory skin and bowel disease, 13q12.3 microdeletion syndrome, zinc-responsive necrolytic acral erythema, keratosis pilaris atrophicans, ichthyosis, erythrokeratoderma, hereditary palmoplantar keratoderma, inherited epidermolysis bullosa, punctate acrokeratoderma freckle-like pigmentation, aquagenic palmoplantar keratoderma, phrynoderma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.